P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer. 2020

Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
School of Pharmaceutical Sciences, Health Science Center, Shenzhen Technology University, Shenzhen, 518060, PR China.

The p21-Activated kinase 1 (PAK1), a member of serine-threonine kinases family, was initially identified as an interactor of the Rho GTPases RAC1 and CDC42, which affect a wide range of processes associated with cell motility, survival, metabolism, cell cycle, proliferation, transformation, stress, inflammation, and gene expression. Recently, the PAK1 has emerged as a potential therapeutic target in cancer due to its role in many oncogenic signaling pathways. Many PAK1 inhibitors have been developed as potential preclinical agents for cancer therapy. Here, we provide an overview of essential roles that PAK1 plays in cancer, including its structure and autoactivation mechanism, its crucial function from onset to progression to metastasis, metabolism, immune escape and even drug resistance in cancer; endogenous regulators; and cancer-related pathways. We also summarize the reported PAK1 small-molecule inhibitors based on their structure types and their potential application in cancer. In addition, we provide overviews on current progress and future challenges of PAK1 in cancer, hoping to provide new ideas for the diagnosis and treatment of cancer.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D054462 p21-Activated Kinases A family of serine-threonine kinases that bind to and are activated by MONOMERIC GTP-BINDING PROTEINS such as RAC GTP-BINDING PROTEINS and CDC42 GTP-BINDING PROTEIN. They are intracellular signaling kinases that play a role the regulation of cytoskeletal organization. PAK Kinase,p21-Activated Kinase,Oligophrenin-3,PAK Kinases,PAK-1 Kinase,PAK-2 Kinase,PAK1 Kinase,PAK2 Kinase,PAK3 Kinase,PAK65,Serine-Threonine-Protein Kinase PAK 1,Serine-Threonine-Protein Kinase PAK 3,alpha p21-Activated Kinase,alpha-PAK,beta p21-Activated Kinase,beta-PAK,gamma-PAK,p21-Activated Kinase 1,p21-Activated Kinase 2,p21-Activated Kinase 3,p65(PAK),p65PAK Protein,Kinase, PAK,Kinase, p21-Activated,Kinases, PAK,Kinases, p21-Activated,Oligophrenin 3,PAK 1 Kinase,PAK 2 Kinase,Serine Threonine Protein Kinase PAK 1,Serine Threonine Protein Kinase PAK 3,alpha p21 Activated Kinase,beta p21 Activated Kinase,gamma PAK,p21 Activated Kinase,p21 Activated Kinase 1,p21 Activated Kinase 2,p21 Activated Kinase 3,p21 Activated Kinases,p21-Activated Kinase, beta
D054852 Small Molecule Libraries Large collections of small molecules (molecular weight about 600 or less), of similar or diverse nature which are used for high-throughput screening analysis of the gene function, protein interaction, cellular processing, biochemical pathways, or other chemical interactions. It includes virtual libraries. Chemical Libraries,Molecular Libraries, Small,Libraries, Chemical,Libraries, Small Molecular,Libraries, Small Molecule,Molecule Libraries, Small,Small Molecular Libraries
D019008 Drug Resistance, Neoplasm Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures. Antibiotic Resistance, Neoplasm,Antineoplastic Drug Resistance,Drug Resistance, Antineoplastic,Antineoplastic Agent Resistance,Neoplasm Drug Resistance,Resistance, Antineoplastic Agent,Resistance, Antineoplastic Drug

Related Publications

Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
January 2004, Cancer treatment and research,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
February 2023, Journal of translational medicine,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
June 2011, Oncotarget,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
May 2005, The Journal of biological chemistry,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
November 2002, Journal of cellular physiology,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
August 2016, Annals of oncology : official journal of the European Society for Medical Oncology,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
September 2010, Biochemical pharmacology,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
January 2016, World journal of gastroenterology,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
September 2008, Journal of cellular biochemistry,
Dahong Yao, and Chenyang Li, and Muhammad Shahid Riaz Rajoka, and Zhendan He, and Jian Huang, and Jinhui Wang, and Jin Zhang
January 2013, PloS one,
Copied contents to your clipboard!